News - Novo Nordisk, Licensing

Filter

Current filters:

Novo NordiskLicensing

Popular Filters

Novo Nordisk ups stake in Innate Pharma along with sale of anti-NKG2A

Novo Nordisk ups stake in Innate Pharma along with sale of anti-NKG2A

07-02-2014

Danish insulin giant Novo Nordisk has sold full development and commercialization rights to the anti-NKG2A…

anti-NKG2AInnate PharmaLicensingMergers & AcquisitionsNovo NordiskOncologyPharmaceutical

Emisphere earns $10 million on amended deal with Novo Nordisk

30-04-2013

USA-based Emisphere Technologies (OTCBB: EMIS) says that it has agreed with Danish insulin giant Novo…

DiabetesEmisphereLicensingNovo NordiskPharmaceuticalResearch

Mylan extends deal with Bioton to biosimilar insulins, as Actavis pulls out of JV

14-02-2013

US generic drugmaker Mylan (Nasdaq: MYL) said yesterday that it has entered into a definitive agreement…

ActavisBiotechnologyBiotonDiabetesEli LillyGenericsHumalogLantusLicensingMarkets & MarketingMylan LaboratoriesNovo NordiskNovoLogSanofi

Novo Nordisk to acquire Taiwanese osteo/RA technology

17-05-2012

Danish insulin giant Novo Nordisk (NOV: N) has acquired rights to technology developed by a southern…

Anti-Arthritics/RheumaticsLicensingNovo NordiskPharmaceuticalResearch

Novo Nordisk in-licenses drug delivery technology from Caisson

01-05-2012

Danish insulin giant Novo Nordisk (NVO: N) has entered into a development and license agreement with…

Caisson BiotechHeparinexLicensingNovo NordiskPharmaceutical

Pfizer and Biocon cancel biosimilars deal

14-03-2012

Indian biotech firm Biocon (BSE: 532523) and global drugs behemoth Pfizer (NYSE: PFE) yesterday announced…

Asia-PacificBioconBiotechnologyDiabetesInsulinLicensingNovo NordiskPfizerPharmaceutical

Back to top